Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01114477 · ClinicalTrials.gov registry record
NeuroStar TMS Therapy System: Utilization and Outcomes
A clinical trial of Major Depressive Disorder, sponsored by Neuronetics.
- Completed
- Registry status
- 307
- Enrollment target
- 20
- Study locations
NCT01114477 is a study of Major Depressive Disorder that has completed, run by Neuronetics. The registered enrollment target is 307 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (18% lower). The trial reports 20 study locations across 7 states.
The verdict
NCT01114477, a study of Major Depressive Disorder, has completed, sponsored by Neuronetics.
- COMPLETED
- Registry status
- 307 participants
- Enrollment target
- 20
- Study locations
Study Summary
The major objective of this observational study is to describe clinical outcomes of patients receiving treatment with the NeuroStar TMS Therapy system in routine clinical practice.
Conditions Studied
Study Locations (20)
California
- Bay Psychiatric Associates - Berkeley
- TMS Center of Beverly Hills - Beverly Hills
- Clinical Training & Research Institute - Burlingame
- Sacramento TMS - El Dorado Hills
- Martha Koo, MD - Hermosa Beach
- Orange County TMS Center - Laguna Hills
- Depression Research Center and Clinic-Semel Institute for Neuroscience & Human Behavior at UCLA - Los Angeles
- Kevin Kinback, MD - Mission Viejo
- Todd Hutton, MD & Associates - Pasadena
- The Botkiss Center for TMS Therapy - San Diego
- Stanford Hospital and Clinics - Stanford
- Arjun Reyes, MD - Woodland Hills
Connecticut
- Hartford Hospital - Hartford
- Comprehensive Psychiatric Care - Norwich
Florida
- Health Sciences America, LLC - Boca Raton
- Curtis Cassidy, MD - Lakeland
Arizona
- Lee Ann Kelley, M.D., PC - Phoenix
Delaware
- Christiana Care Health Services - Wilmington
Georgia
- Brian Teliho, MD - Atlanta
Illinois
- Carl M. Wahlstrom, Jr. MD Limited - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2010-03 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01114477
The ClinicalTrials.gov registry entry for NCT01114477 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 307 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (18% lower). The listed sponsor is Neuronetics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT01114477 reports 20 study locations spanning 7 distinct geographic areas - top geographies include California, Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT01114477 about?
NCT01114477 is a clinical study titled "NeuroStar TMS Therapy System: Utilization and Outcomes". The major objective of this observational study is to describe clinical outcomes of patients receiving treatment with the NeuroStar TMS Therapy system in routine clinical practice.
What is the current status of trial NCT01114477?
This trial is currently completed. The enrollment target is 307 participants. The study started on 2010-03. Estimated completion is 2012-09.
What conditions does trial NCT01114477 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
Who is sponsoring clinical trial NCT01114477?
This trial is sponsored by Neuronetics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01114477 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Delaware, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
RECRUITING · Early Phase 1
-
Taking Action for College Students
RECRUITING · NA
-
Neural Response to Inflammatory Challenge in Major Depressive Disorder
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.